The PROTAC selectively degrading Bcl-x<sub>L</sub> represents a novel Hedgehog pathway inhibitor with capacity of combating resistance to Smoothened inhibitors while sparing bone growthShaoqing Zhang, Wenfu Tan|Theranostics|2022Cited by 20